By David Tuller, DrPH
The National Institutes of Health is making a $2.1 million grant to the UK ME/CFS Biobank–a huge endorsement of this important project run by CureME and housed at the London School of Hygiene and Tropical Medicine. Here’s what the ME Association wrote on its website:
“The funding represents the biggest ever single investment in biomedical research to happen in the UK and it will enable a current project, that is searching for disease biomarkers, to be extended for another 4 years – until 2021.
The project is a longitudinal study that is measuring changes in the immune system and genetic profile of individuals in a disease whose symptoms are known to fluctuate over time. The initial £1 million project, which began in 2013, was over 3 years and had also been made possible by funding from NIH.”
The announcement comes a few weeks after the annual conference of the CFS/ME Research Collaborative, which has backed a parallel project called the ME/CFS Epidemiology and Genomics Alliance (MEGA). At the CMRC gathering, the organization’s chair, Professor Stephen Holgate, extolled his colleague, Professor Esther Crawley, for her “amazing” and “stunning” work on MEGA–even as he announced that the project had failed its recent bid for funding from the Medical Research Council.
To read the rest of this story, click on the link below: